Marvel unveiled a new trailer for Avengers: Doomsday at CinemaCon, centering on Robert Downey Jr.'s debut as Doctor Doom and the return of Chris Evans as Steve Rogers. Patrick Stewart's Professor Xavier anchors a key trailer moment, warning of an unstoppable threat and an "unthinkable" confrontation ahead. The footage signals a broad ensemble scope, with Marvel leaning into multiverse-era character returns to anchor what is being positioned as a high-stakes franchise event. For the studio, the CinemaCon reveal serves a clear commercial function: securing exhibitor enthusiasm and sustaining theatrical momentum heading into what is likely a major release window. The trailer's dual hooks, Downey's villain pivot and Evans's return, are designed to convert lapsed Marvel viewers into opening-weekend ticket buyers. Box office performance will hinge on whether the studio can consolidate a fanbase that has been uneven in its engagement since Avengers: Endgame. Theater chains and investors will watch pre-sale data closely as a near-term demand signal.
Flipkart will launch a food delivery pilot in Bengaluru by mid-August, charging restaurants a 10-11% commission compared to the 25-35% levied by Swiggy and Zomato. The move targets growing restaurant discontent with incumbent platforms and aims to drive daily engagement across Flipkart's 500 million registered users.
Maruti Suzuki crossed two lakh domestic units in July 2026 for the first time, recording 42.4% year-on-year growth. Total sales including exports and OEM supplies reached 2,41,421 units, with all passenger vehicle segments posting gains.
Air India's net loss more than doubled to ₹22,238 crore in FY26, prompting Tata Sons chairman N Chandrasekaran to extend the Vihaan.AI turnaround timeline from five years to as long as a decade.
UpGrad's all-stock acquisition of Unacademy, valued at Rs 1,955 crore, is set to close within three weeks after CCI clearance and near-complete investor sign-offs. The deal combines upGrad's upskilling business with Unacademy's test prep and medical education platforms, with Gaurav Munjal staying on as CEO.
